India's Shilpa Medicare rises on German drug marketing approval

Shilpa Medicare

19/01/2024 08:04

** Shares of Shilpa Medicare  SHME.NS  up as much as 2.7% to
338.9 rupees
    ** The pharmaceutical company receives marketing
authorisation from Germany for drug used to treat a number of
rare muscle diseases
    ** Stock on track to gain for second consecutive week
    ** Stock has been trading above 200-day moving avg since
June 30, 2023
    ** Stock was up 18.7% in 2023

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))